Anja Kahl

742 total citations
15 papers, 450 citations indexed

About

Anja Kahl is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Anja Kahl has authored 15 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Anja Kahl's work include Mitochondrial Function and Pathology (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and ATP Synthase and ATPases Research (2 papers). Anja Kahl is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers) and ATP Synthase and ATPases Research (2 papers). Anja Kahl collaborates with scholars based in United States, Germany and Canada. Anja Kahl's co-authors include Costantino Iadecola, Giovanni Manfredi, Ping Zhou, Анна Степанова, Corey J. Anderson, Alexander Galkin, Csaba Konràd, Alexander B. Kowski, Rüdiger W. Veh and Anatoly A. Starkov and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Stroke and Scientific Reports.

In The Last Decade

Anja Kahl

14 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anja Kahl United States	9	235	83	70	54	50	15	450
Jing Zou China	9	171 0.7×	101 1.2×	54 0.8×	72 1.3×	148 3.0×	11	485
Guoxu Xu China	16	329 1.4×	43 0.5×	43 0.6×	58 1.1×	33 0.7×	27	794
В. С. Сухоруков Russia	8	251 1.1×	68 0.8×	46 0.7×	88 1.6×	28 0.6×	81	379
Lilja Meissner Germany	7	243 1.0×	103 1.2×	78 1.1×	61 1.1×	97 1.9×	8	521
Ndidi-Ese Uzor United States	9	246 1.0×	53 0.6×	114 1.6×	86 1.6×	34 0.7×	11	439
Sarah Almond United Kingdom	14	200 0.9×	140 1.7×	43 0.6×	40 0.7×	58 1.2×	24	684
Alexanne Cuillerier Canada	11	303 1.3×	29 0.3×	101 1.4×	94 1.7×	30 0.6×	25	503
Andrew M. Slupe United States	8	237 1.0×	62 0.7×	56 0.8×	42 0.8×	92 1.8×	9	491
Joanne F. Garbincius United States	8	345 1.5×	66 0.8×	36 0.5×	97 1.8×	21 0.4×	14	464
Mónica George Spain	9	313 1.3×	48 0.6×	44 0.6×	68 1.3×	18 0.4×	20	708

Countries citing papers authored by Anja Kahl

Since Specialization

Citations

This map shows the geographic impact of Anja Kahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Kahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Kahl more than expected).

Fields of papers citing papers by Anja Kahl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Kahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Kahl. The network helps show where Anja Kahl may publish in the future.

Co-authorship network of co-authors of Anja Kahl

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Kahl. A scholar is included among the top collaborators of Anja Kahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Kahl. Anja Kahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Poon, Carrie, Anja Kahl, Ulrike Resch, et al.. (2024). Post-ischemic ubiquitination at the postsynaptic density reversibly influences the activity of ischemia-relevant kinases. Communications Biology. 7(1). 321–321. 3 indexed citations

Kahl, Anja, Mark Donovan, Manuj Ahuja, et al.. (2024). TargetTau‐1: Design of a phase 2 trial to evaluate the efficacy, safety, and tolerability of BMS‐986446, an anti‐MTBR tau monoclonal antibody, in patients with early Alzheimer’s disease. Alzheimer s & Dementia. 20(S8). 2 indexed citations

Liu, Xuejun, Jenny Jiang, Danshi Li, et al.. (2023). Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom. Cardiology and Therapy. 12(4). 675–687. 2 indexed citations

Sharma, Mukul, Carlos A. Molina, Ḱazunori Toyoda, et al.. (2022). Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention. Journal of Stroke and Cerebrovascular Diseases. 31(10). 106742–106742. 32 indexed citations

Benz, Alexander P., John W. Eikelboom, Salim Yusuf, et al.. (2020). Long-Term Treatment with Apixaban in Patients with Atrial Fibrillation: Outcomes during the Open-Label Extension following AVERROES. Thrombosis and Haemostasis. 121(4). 518–528. 5 indexed citations

Anderson, Corey J., Anja Kahl, Liping Qian, et al.. (2019). Prohibitin levels regulate OMA1 activity and turnover in neurons. Cell Death and Differentiation. 27(6). 1896–1906. 47 indexed citations

Anderson, Corey J., Anja Kahl, Liping Qian, et al.. (2018). Prohibitin is a positive modulator of mitochondrial function in PC12 cells under oxidative stress. Journal of Neurochemistry. 146(3). 235–250. 30 indexed citations

Kahl, Anja, et al.. (2018). Cerebral ischemia induces the aggregation of proteins linked to neurodegenerative diseases. Scientific Reports. 8(1). 2701–2701. 70 indexed citations

Kahl, Anja, Анна Степанова, Csaba Konràd, et al.. (2018). Critical Role of Flavin and Glutathione in Complex I–Mediated Bioenergetic Failure in Brain Ischemia/Reperfusion Injury. Stroke. 49(5). 1223–1231. 67 indexed citations

10.

Степанова, Анна, Anja Kahl, Csaba Konràd, et al.. (2017). Reverse electron transfer results in a loss of flavin from mitochondrial complex I: Potential mechanism for brain ischemia reperfusion injury. Journal of Cerebral Blood Flow & Metabolism. 37(12). 3649–3658. 52 indexed citations

11.

Kahl, Anja, Corey J. Anderson, Liping Qian, et al.. (2017). Neuronal expression of the mitochondrial protein prohibitin confers profound neuroprotection in a mouse model of focal cerebral ischemia. Journal of Cerebral Blood Flow & Metabolism. 38(6). 1010–1020. 13 indexed citations

12.

Kahl, Anja, Анна Степанова, Csaba Konràd, et al.. (2016). Complex I mediated bioenergetic failure in acute ischemic brain injury. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 1857. e78–e79. 1 indexed citations

13.

Kampf, D., Anja Kahl, Kai‐Uwe Eckardt, et al.. (2015). Single-Dose Kinetics of Recombinant Human Erythropoietin after Intravenous, Subcutaneous and Intraperitoneal Administration. Contributions to nephrology. 76. 106–111.

14.

Mergenthaler, Philipp, Anja Kahl, Vincent van Laak, et al.. (2012). Mitochondrial hexokinase II (HKII) and phosphoprotein enriched in astrocytes (PEA15) form a molecular switch governing cellular fate depending on the metabolic state. Proceedings of the National Academy of Sciences. 109(5). 1518–1523. 57 indexed citations

15.

Kahl, Anja, et al.. (2007). Dopaminergic projections from the VTA substantially contribute to the mesohabenular pathway in the rat. Neuroscience Letters. 427(3). 165–170. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact